CIBC Bancorp USA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135M Sell
345,355
-35,833
-9% -$14.3M 0.17% 132
2026
Q2
$147M Sell
381,188
-81,239
-18% -$30.1M 0.18% 134
2026
Q1
$135M Buy
+462,427
New +$152M 0.18% 124
2025
Q3
$10M Buy
+31,094
New +$9.7M 0.05% 255

Other funds holding ELV

CIBC Bancorp USA's ELV Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Elevance Health (ELV) stake by 9.4% in Q3 2026, selling an estimated $14.3M and leaving 345,355 shares worth $135M. The position accounts for 0.17% of the portfolio, ranked #132.

CIBC Bancorp USA first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $147M in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • CIBC Bancorp USA held 345,355 shares of Elevance Health worth $135M as of Q3 2026.
  • CIBC Bancorp USA sold 35,833 Elevance Health shares in Q3 2026, an estimated $14.3M.
  • Elevance Health made up 0.17% of CIBC Bancorp USA's portfolio in Q3 2026, its #132 holding.
  • CIBC Bancorp USA first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Elevance Health position peaked at $147M in Q2 2026.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.